DICERNA PHARMACEUTICALS Trademark

Trademark Overview

On Monday, March 24, 2014, a trademark application was filed for DICERNA PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the DICERNA PHARMACEUTICALS trademark a serial number of 86230735. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 20, 2017. This trademark is owned by Dicerna Pharmaceuticals, Inc.. The DICERNA PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of rare diseases defined by genetics, Primary Hyperoxaluria, and Alpha 1 anti-trypsin deficiency; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
dicerna pharmaceuticals

General Information

Serial Number86230735
Word MarkDICERNA PHARMACEUTICALS
Filing DateMonday, March 24, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 20, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 19, 2014

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS"
Description of MarkThe mark consists of A vertical double helix is positioned to the left of the words "DICERNA PHARMACEUTICALS". The word "DICERNA" is stacked directly above the word "PHARMACEUTICALS". A left pointing arrow head is positioned at the base of the letter "D" of "DICERNA",splicing the double helix.
Goods and Servicespharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of rare diseases defined by genetics, Primary Hyperoxaluria, and Alpha 1 anti-trypsin deficiency; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 28, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDicerna Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameDicerna Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Monday, November 20, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 20, 2017ABANDONMENT - NO USE STATEMENT FILED
Friday, April 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 20, 2017EXTENSION 5 GRANTED
Friday, April 7, 2017EXTENSION 5 FILED
Friday, April 7, 2017TEAS EXTENSION RECEIVED
Wednesday, November 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 1, 2016EXTENSION 4 GRANTED
Thursday, October 13, 2016EXTENSION 4 FILED
Thursday, October 13, 2016TEAS EXTENSION RECEIVED
Thursday, May 19, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 19, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 4, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 3, 2016EXTENSION 3 GRANTED
Tuesday, April 5, 2016EXTENSION 3 FILED
Tuesday, April 5, 2016TEAS EXTENSION RECEIVED
Friday, October 9, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 8, 2015EXTENSION 2 GRANTED
Monday, October 5, 2015EXTENSION 2 FILED
Thursday, October 8, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 5, 2015TEAS EXTENSION RECEIVED
Friday, April 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2015EXTENSION 1 GRANTED
Wednesday, April 8, 2015EXTENSION 1 FILED
Wednesday, April 8, 2015TEAS EXTENSION RECEIVED
Wednesday, April 1, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 1, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 19, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 19, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 30, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 16, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 16, 2014ASSIGNED TO LIE
Saturday, June 28, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 28, 2014EXAMINER'S AMENDMENT ENTERED
Saturday, June 28, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, June 28, 2014EXAMINERS AMENDMENT E-MAILED
Saturday, June 28, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 25, 2014ASSIGNED TO EXAMINER
Saturday, March 29, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, March 28, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 27, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals dicerna pharmaceutical preparations delivery treatment drug other agents products compounds range